Skip to main content
    R

    Rallybio Corp (RLYB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $15.43
    -0.30 (-1.88%)

    Market Cap: $88.03M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Rallybio Corp (RLYB) Earnings: Report Dates and Results

    Updated Oct 27, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Rallybio reported EPS of -$0.48. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    57%(12/21)
    Avg Surprise
    +26.98%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$1.61
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    RLYB's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 21 quarters below that had an estimate, RLYB beat 12, missed 8 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2025, when EPS landed 284.62% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.48-$1.44-$1.44 - -$1.44N/AN/A-116.7%10 up, 0 downOct 27, 2026N/A
    Jun 30, 2026-$1.09-$1.28-$1.28 - -$1.28+14.84%BeatN/A10 up, 0 downAug 6, 2026N/A
    Mar 31, 2026-$1.46-$1.20-$1.20 - -$1.20-21.67%MissN/A11 up, 0 downMay 13, 2026$212000
    Dec 31, 2025-$1.52-$1.23-$1.28 - -$1.20-23.94%Miss-708.0%20 up, 1 downMar 12, 2026$222000
    Sep 30, 2025$2.88-$1.56-$1.76 - -$1.36+284.62%BeatN/A20 up, 1 downNov 6, 2025$212000
    Jun 30, 2025-$0.22-$0.25-$0.26 - -$0.23+10.20%BeatN/A21 up, 1 downAug 7, 2025$212000
    Mar 31, 2025-$1.68-$2.28-$2.48 - -$2.08+26.32%BeatN/A21 up, 0 downMay 8, 2025$212000
    Dec 31, 2024$0.25-$0.30-$0.32 - -$0.28+183.33%BeatN/A32 up, 1 downMar 13, 2025$38000
    Sep 30, 2024-$2.08-$2.70-$3.28 - -$2.56+22.96%BeatN/A50 up, 0 downNov 7, 2024$299000
    Jun 30, 2024-$2.96-$2.86-$3.68 - -$2.00-3.50%MissN/A50 up, 0 downAug 8, 2024$299000
    Mar 31, 2024-$3.76-$3.68-$4.24 - -$2.88-2.17%MissN/A50 up, 0 downMay 9, 2024N/A
    Dec 31, 2023-$0.50-$0.45-$0.52 - -$0.36-11.11%MissN/A70 up, 0 downMar 12, 2024$228000
    Sep 30, 2023-$3.60-$3.98-$4.40 - -$3.84+9.55%BeatN/A70 up, 0 downNov 9, 2023N/A
    Jun 30, 2023-$3.68-$3.77-$4.16 - -$3.44+2.39%BeatN/A70 up, 0 downAug 8, 2023N/A
    Mar 31, 2023-$3.44-$3.72-$4.40 - -$3.04+7.53%BeatN/A70 up, 0 downMay 9, 2023N/A
    Dec 31, 2022-$0.46-$0.60-$0.64 - -$0.50+23.33%BeatN/A50 up, 0 downMar 6, 2023N/A
    Sep 30, 2022-$4.80-$4.32-$4.48 - -$4.16-11.11%MissN/A40 up, 0 downNov 7, 2022N/A
    Jun 30, 2022-$4.56-$4.88N/A+6.56%BeatN/AN/A0 up, 0 downAug 8, 2022N/A
    Mar 31, 2022-$3.84-$3.76-$4.00 - -$3.20-2.13%MissN/A40 up, 0 downMay 10, 2022N/A
    Dec 31, 2021-$0.42-$0.39-$0.43 - -$0.34-7.69%MissN/A40 up, 0 downMar 15, 2022N/A
    Sep 30, 2021-$2.96-$7.08-$8.48 - -$5.68+58.19%BeatN/A2N/ANov 10, 2021N/A
    Jun 30, 2021-$2.80-$2.80N/A0.00%In lineN/A20 up, 0 downSep 9, 2021N/A
    Mar 31, 2021-$4.11N/AN/AN/AN/AN/AN/AN/AJun 2, 2021N/A
    Dec 31, 2020-$4.11N/AN/AN/AN/AN/AN/AN/AMar 31, 2021N/A
    Dec 31, 2019-$1.97N/AN/AN/AN/AN/AN/AN/AMar 31, 2020N/A
    Last 25 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.54, after -$8.55 the year before. It was -$1.97 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.54N/A
    Dec 31, 2024-$8.55N/A
    Dec 31, 2023-$11.22N/A
    Dec 31, 2022-$13.66N/A
    Dec 31, 2021-$10.29N/A
    Dec 31, 2020-$4.11N/A
    Dec 31, 2019-$1.97N/A

    Frequently Asked Questions About RLYB

    What EPS do analysts expect from RLYB next quarter?

    The consensus EPS estimate for Rallybio for the quarter ending Dec 31, 2026 is -$1.61 from 3 analysts.

    How often does RLYB beat earnings estimates?

    Rallybio beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of +62.08%.